Cart
sales@molnova.com
Alacepril
CAS No. 74258-86-9
Alacepril( Cetapril | DU-1219 )
Catalog No. M21079 CAS No. 74258-86-9
Alacepril is a relatively novel angiotensin-converting enzyme inhibitor used as an antihypertensive.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | Get Quote |
|
| 25MG | 73 | Get Quote |
|
| 50MG | 110 | Get Quote |
|
| 100MG | 164 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAlacepril
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlacepril is a relatively novel angiotensin-converting enzyme inhibitor used as an antihypertensive.
-
DescriptionAlacepril is a relatively novel angiotensin-converting enzyme inhibitor used as an antihypertensive.(In Vivo):The long lasting antihypertensive effect of Alacepril in renal hypertensive rats is confirmed by once daily successive oral administration (1-2 mg/kg/d). In renal hypertensive dogs, Alacepril (3 mg/kg) showed a stable and sustained hypotensive effect, and its duration of action was longer than that of captopril.
-
In Vitro——
-
In VivoThe long lasting antihypertensive effect of Alacepril in renal hypertensive rats is confirmed by once daily successive oral administration (1-2 mg/kg/d). In renal hypertensive dogs, Alacepril (3 mg/kg) showed a stable and sustained hypotensive effect, and its duration of action was longer than that of captopril.
-
SynonymsCetapril | DU-1219
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorAngiotensin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number74258-86-9
-
Formula Weight406.5
-
Molecular FormulaC20H26N2O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (246.00 mM)
-
SMILESCC(=O)SCC(C)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)O
-
Chemical Name(3-(acetylthio)-2-methylpropanoyl)-L-prolyl-L-phenylalanine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kinugawa T Osaki S Kato M et al. Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure[J]. Clin Exp Pharmacol Physiol 2002 29(12):1060-1065.
molnova catalog
related products
-
H-Val-Pro-Pro-OH
H-Val-Pro-Pro-OH is an inhibitor of Angiotensin I converting enzyme (ACE)( IC50 : 9 μM).
-
Irbesartan
Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension.
-
Nitrosoglutathione
GSNO is an endogenous transnitrosation donor involved in S-nitrosation of a variety of cellular proteins. GSNO, an exogenous NO donor and substrate of rat alcohol dehydrogenase class III isoenzyme, inhibits cerebral angiotensin II-dependent and -independent AT1 receptor responses.
